Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban in Obesity Patients Before and After Bariatric Surgery
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Pharmacokinetics
- 25 Jan 2017 Results published in the British Journal of Clinical Pharmacology
- 07 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jun 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov.